Effect of Sodium Dextrothyroxine in Patients Receiving Anticoagulants
- 11 January 1962
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 266 (2) , 76-79
- https://doi.org/10.1056/nejm196201112660205
Abstract
ANY new therapeutic agent brings with it the problem of identifying side effects that would not ordinarily be attributed to the particular drug. The effectiveness of dextrothyroxine in reducing serum cholesterol has been previously reported.1 , 2 Earlier, we observed that anticoagulated patients receiving this drug tended to require lower anticoagulant dosages (this has been reported by other observers3). It is the purpose of this work to investigate this effect of dextrothyroxine on the clotting mechanism.MethodsA group of 14 patients, 7 males and 7 females, were studied. Eleven of these were selected from those attending the anticoagulant clinic of . . .Keywords
This publication has 7 references indexed in Scilit:
- Effect of Sodium Dextrothyroxine on Serum Cholesterol in ManPublished by American Medical Association (AMA) ,1961
- Determination of prothrombin concentration as an index of anticoagulant controlThe American Journal of Cardiology, 1961
- Reduction of Serum Cholesterol by Sodium Dextro-ThyroxineArchives of internal medicine (1960), 1960
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951
- Some Clinical Observations on the Prothrombin TestAmerican Journal of Clinical Pathology, 1947
- The Clinical Application of the Hippuric Acid and the Prothrombin TestsAmerican Journal of Clinical Pathology, 1940